ANNEX I, Regulation (EU) 2015/2085

In force

[Further details on identity and specification of active substance are provided in the review report.]

Common Name, Identification Numbers | IUPAC Name | Purity | Date of approval | Expiration of approval | Specific provisions

Mandestrobin

CAS No: 173662-97-0

CIPAC No: Not available

(RS)-2-methoxy-N-methyl-2-[α-(2,5-xylyloxy)-o-tolyl]acetamide |

≥ 940 g/kg (on a dry weight basis)

Xylenes (ortho, meta, para), ethyl benzene max. 5 g/kg (TK)

9 December 2015 | 9 December 2025 |

For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on mandestrobin, and in particular Appendices I and II thereof, shall be taken into account.

In this overall assessment Member States shall pay particular attention to:

the risk to aquatic organisms,

the protection of groundwater, when the substance is applied in regions with vulnerable soil and/or climatic conditions.

Conditions of use shall include risk mitigation measures, where appropriate.

The applicant shall submit confirmatory information as regards:

(1)

the technical specification of the active substance as manufactured (based on commercial scale production) including the relevance of some individual impurities;

(2)

the compliance of the toxicity batches with the confirmed technical specification.

The applicant shall submit that information to the Commission, the Member States and the Authority by 9 June 2016.